Skip to content

Ayurvedic management of Endometriosis

EFFICACY OF VIRECHANA KARMA, DASHAMOOLA TRIVRUTA TAILA MATRA BASTI AND GUDUCHYADI KASHAYA ORALLY IN THE MANAGEMENT OF ENDOMETRIOSIS - A SINGLE ARM OPEN LABELLED CLINICAL TRIAL - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081685
Enrollment
15
Registered
2025-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both married and unmarried females of above age group Patients having clinical signs and symptoms of endometriosis Already known case of Endometriosis Patients having CA-125 level less than 500U/ML Patients having chocolate cyst size less than 7cm Patients eligible for Virechana Karma and Basti Patients willing to participate in trial

Exclusion criteria

Exclusion criteria: Patients having age less than 18years and more than 50year Patients having chocolate cyst size more than 7cm Patients having CA-125 level more than 500U/ML Patients having endometriosis of sites other than pelvis and scar endometriosis. Known case of Carcinoma, Congenital anomaly or infectious diseases of reproductive tract like Tuberculosis, STDs, etc. Patients with history of cardiac diseases, chronic liver disease, uncontrolled hypertension (Systolic BP above 160 & Diastolic above 100 mmHg), uncontrolled diabetes mellitus (above the range of 160 mg/dl - RBS) Patients not eligible for Virechana Karma and Basti and not willing to participate in trial.

Design outcomes

Primary

MeasureTime frame
(a) Improvement in clinical features of Endometriosis (b)Improvement in Quality of life.Timepoint: During the treatment period of 4 months

Secondary

MeasureTime frame
(a) Reduction in the size of Endometriosis.Timepoint: After the treatment period of 4 months

Countries

India

Contacts

Public ContactProf Shilpa B Donga

Institute of Teaching and Research in Ayurveda, INI, Jamnagar, Gujarat

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026